Related Experiment Video
Updated: Apr 1, 2026

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery
Published on: May 16, 2021
Advances in the Drug Discovery and Development Pipeline and Emerging Drug Targets
Divya Tiwari1, Anthony Musaazi Kaweesa2, Shannon Fox3
1Blizard Institute, Queen Mary University of London, London E1 2AT, United Kingdom s.tiberi@qmul.ac.uk d.tiwari@qmul.ac.uk.
None:
Tuberculosis (TB) remains a critical global health challenge, disproportionately affecting populations in resource-limited settings and vulnerable groups such as children, pregnant individuals, and people living with human immunodeficiency virus (HIV). Despite significant progress in TB treatment and drug development, challenges, including antimicrobial resistance, drug-drug interaction, toxicity, and limited data in special populations, persist. This work explores the transformative advancements in TB therapeutics and the strategic priorities for improving outcomes, overcoming emerging resistance, and ameliorating tolerability.
More Related Videos
Related Concept Videos
Drug Discovery: Overview
Pharmacogenomics: Identification of New Drug Targets
Targets for Drug Action: Overview
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
Preclinical Development: Overview
Drug Administration and Therapy Phases: Overview
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...

